[HTML][HTML] Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria

R Peces, A Aguilar, C Vega, E Cuesta… - Nefrología (English …, 2012 - revistanefrologia.com
Antecedentes: En la poliquistosis renal autosómica dominante (PQRAD), la hematuria
macroscópica por la rotura de quistes renales es una manifestación habitual, que puede ser …

Treatment of persistent gross hematuria with tranexamic acid in autosomal dominant polycystic kidney disease

Q Yao, M Wu, J Zhou, M Zhou, D Chen, L Fu… - Kidney and Blood …, 2017 - karger.com
Abstract Background/Aims: In this retrospective study we aimed to compare the effect of
tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in …

Tranexamic acid treatment of life‐threatening hematuria in polycystic kidney disease

T AlAmeel, M West - International journal of nephrology, 2011 - Wiley Online Library
A 41‐year‐old woman with autosomal dominant polycystic kidney disease had chronic
kidney disease class IV. She presented 10 days postpartum with a 4‐day history of severe …

A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid

B Vujkovac, M Sabovic - Blood coagulation & fibrinolysis, 2006 - journals.lww.com
We describe a successful treatment of a severe, persistent bleeding from both kidneys in a
patient with autosomal dominant polycystic kidney disease (ADPKD) with tranexamic acid …

Treatment of gross hematuria in autosomal dominant polycystic kidney disease with aprotinin and desmopressin acetate

U Zwettler, M Zeier, K Andrassy, S Geberth… - Nephron, 1992 - scholar.archive.org
In the following, we report on a 30-year-old male with ADPKD. A life-threatening gross
hematuria developed after strenous physical exercise. The patient was admitted to our ward …

[HTML][HTML] Management of nephrolithiasis in autosomal dominant polycystic kidney disease—a single center experience

R Baishya, DR Dhawan, A Kurien, A Ganpule… - Urology …, 2012 - journals.lww.com
Purpose: To evaluate available options for the management of nephrolithiasis in patients
with autosomal dominant polycystic kidney disease (ADPKD). Materials and Methods: Case …

Evaluation and management of gross hematuria in autosomal dominant polycystic kidney disease: a point of care guide for practicing internists

B Bhasin, M Alzubaidi, JCQ Velez - The American Journal of the Medical …, 2018 - Elsevier
Gross hematuria is common in autosomal dominant polycystic kidney disease (ADPKD). It is
an alarming symptom and may be the first manifestation of ADPKD. Cyst hemorrhage is a …

Nephrolithiasis in autosomal dominant polycystic kidney disease

UB Mufti, SK Nalagatla - Journal of endourology, 2010 - liebertpub.com
Abstract Background and Purpose: Autosomal dominant polycystic kidney disease (ADPKD)
manifests with renal and extrarenal abnormalities and is inherited in an autosomal dominant …

KHA-CARI autosomal dominant polycystic kidney disease guideline: management of renal stone disease

A Mallett, M Patel, DJ Tunnicliffe… - Seminars in …, 2015 - seminarsinnephrology.org
Background Nephrolithiasis does commonly complicate ADPKD. When it occurs in ADPKD it
poses additional clinical challenges that are not present in the non-ADPKD population …

[HTML][HTML] The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease

A Idrizi, M Barbullushi, E Petrela, S Kodra, A Koroshi… - Hippokratia, 2009 - ncbi.nlm.nih.gov
Background: Renal stones, urinary tract infections (UTI) and gross hematuria (GH) are the
most important renal manifestations of autosomal dominant polycystic kidney disease …